NEW YORK (GenomeWeb) – Agilent Technologies today announced that its board has approved a share repurchase program for up to a $1.14 billion. 

The buyback program will run through Nov. 1, 2018 and will begin either on Nov. 1, 2015 or when Agilent's previous buyback program is completed. The existing program has $365 million remaining, the Santa Clara, California-based firm said. 

Earlier this month, Agilent reported a 3 percent drop in its fiscal second quarter revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.